KZIA vs AMGN: Which Stock is Better?

Side-by-side comparison of Kazia Therapeutics Ltd and Amgen Inc in 2026

Comparison Updated:

KZIA

Kazia Therapeutics Ltd

$11.22

AMGN

Amgen Inc

$355.30

Key Metrics Comparison

MetricKZIAAMGNWinner
Market Cap$124.78M$188.34BAMGN
P/E RatioN/A24.57AMGN
EPS (TTM)$N/A$14.22AMGN
Revenue Growth3.1%0.1%KZIA
Gross Margin100.0%70.8%KZIA

Analyze KZIA

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is KZIA or AMGN a better investment?

Comparing KZIA and AMGN: Kazia Therapeutics Ltd has a market cap of $124.78M while Amgen Inc has $188.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between KZIA and AMGN?

KZIA (Kazia Therapeutics Ltd) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: KZIA or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: KZIA or AMGN?

KZIA has higher revenue growth at 3.1% vs 0.1% for AMGN.

Which company is more profitable: KZIA or AMGN?

Kazia Therapeutics Ltd (KZIA) has higher gross margins at 100.0% compared to 70.8% for AMGN.

Which is the larger company: KZIA or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $188.34B compared to $124.78M for KZIA.

Should I buy KZIA or AMGN in 2026?

Both KZIA and AMGN have investment merit. KZIA trades at $11.22 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between KZIA and AMGN stock?

Key differences: Market Cap ($124.78M vs $188.34B), P/E Ratio (N/A vs 24.6x), Revenue Growth (3.1% vs 0.1%), Gross Margin (100.0% vs 70.8%).

Popular Stock Comparisons